» Articles » PMID: 35223462

Image Analysis of Circulating Tumor Cells and Leukocytes Predicts Survival and Metastatic Pattern in Breast Cancer Patients

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Feb 28
PMID 35223462
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of the present work was to test whether quantitative image analysis of circulating cells can provide useful clinical information targeting bone metastasis (BM) and overall survival (OS >30 months) in metastatic breast cancer (MBC).

Methods: Starting from cell images of epithelial circulating tumor cells (eCTC) and leukocytes (CD45pos) obtained with DEPArray, we identified the most significant features and applied single-variable and multi-variable methods, screening all combinations of four machine-learning approaches (Naïve Bayes, Logistic regression, Decision Trees, Random Forest).

Results: Best predictive features were circularity (OS) and diameter (BM), in both eCTC and CD45pos. Median difference in OS was 15 vs. 43 (months), p = 0.03 for eCTC and 19 vs. 36, p = 0.16 for CD45pos. Prediction for BM showed low accuracy (64%, 53%) but strong positive predictive value PPV (79%, 91%) for eCTC and CD45, respectively. Best machine learning model was Naïve Bayes, showing 46 vs 11 (months), p <0.0001 for eCTC; 12.5 vs. 45, p = 0.0004 for CD45pos and 11 vs. 45, p = 0.0003 for eCTC + CD45pos. BM prediction reached 91% accuracy with eCTC, 84% with CD45pos and 91% with combined model.

Conclusions: Quantitative image analysis and machine learning models were effective methods to predict survival and metastatic pattern, with both eCTC and CD45pos containing significant and complementary information.

Citing Articles

A Hybrid Intelligence Approach for Circulating Tumor Cell Enumeration in Digital Pathology by Using CNN and Weak Annotations.

Tong L, Wan Y IEEE Access. 2024; 11:142992-143003.

PMID: 38957613 PMC: 11218908. DOI: 10.1109/access.2023.3343701.


Circulating Tumour Cells in the Prediction of Bone Metastasis.

Choi S, Sun A, Cheung J, Ho J Cancers (Basel). 2024; 16(2).

PMID: 38254743 PMC: 10813668. DOI: 10.3390/cancers16020252.


Platelet-Based Liquid Biopsies through the Lens of Machine Learning.

Cygert S, Pastuszak K, Gorski F, Sieczczynski M, Juszczyk P, Rutkowski A Cancers (Basel). 2023; 15(8).

PMID: 37190262 PMC: 10136732. DOI: 10.3390/cancers15082336.

References
1.
Fittall M, Van Loo P . Translating insights into tumor evolution to clinical practice: promises and challenges. Genome Med. 2019; 11(1):20. PMC: 6440005. DOI: 10.1186/s13073-019-0632-z. View

2.
Marshall J, Cook D, Christou N, Bernard G, Sprung C, Sibbald W . Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995; 23(10):1638-52. DOI: 10.1097/00003246-199510000-00007. View

3.
Kologlu M, Elker D, Altun H, Sayek I . Validation of MPI and PIA II in two different groups of patients with secondary peritonitis. Hepatogastroenterology. 2001; 48(37):147-51. View

4.
Muraro E, Comaro E, Talamini R, Turchet E, Miolo G, Scalone S . Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy. J Transl Med. 2015; 13:204. PMC: 4483222. DOI: 10.1186/s12967-015-0567-0. View

5.
Verronese E, Delgado A, Valladeau-Guilemond J, Garin G, Guillemaut S, Tredan O . Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay. Oncoimmunology. 2016; 5(3):e1100791. PMC: 4839376. DOI: 10.1080/2162402X.2015.1100791. View